1)   Mavilio D. *, J. Benjamin, M. Daucher, G. Lombardo, S. Kottilil, M.A. Planta, E. Marcenaro, C. Bottino, L. Moretta, A. Moretta, and A.S. Fauci.

Natural Killer cells in HIV-1 Infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates.

       Proc Natl Acad Sci U S A. 2003 December 9;100(25):15011-6. Impact Factor: 10.896

 

2) Mavilio D.*, Lombardo G, Benjamin J, Kim D, Follman D, Marcenaro E, O’Shea MA, Kinter A, Kovacs C, Moretta A, Fauci AS.

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

     Proc Natl Acad Sci U S A. 2005 February 22; 102(8):2886-91. Impact Factor: 10.231

 

3) Mavilio D.*, Benjamin J, Kim D, Lombardo G, Daucher M, Kinter A, Nies-Kraske E, Marcenaro E, Moretta A, Fauci AS.

Identification of NKG2A and NKp80 as specific Natural Killer cell markers in rhesus and pig-tailed monkeys.

     Blood 2005 September 1; 106(5): 1718-1725. Impact Factor: 10.131

 

4) Fauci A.S., Mavilio D., Kottilil S.

NK cells in HIV infection; paradigm for protection or targets for ambush.

     Nature Review Immunology 2005 November; 5 (11): 835-43. Impact Factor: 30.458

 

5) Mavilio D.*, Lombardo G., Kinter A., Fogli M., La sala A., Ortolano S., Farschi A., Follmann D., Gregg R., Kovacs C., Marcenaro E., Pende D., Moretta A., Fauci A.S.

Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection.

       Journal of Experimental Medicine 2006 October 2; 203(10): 2239-2350. Impact Factor: 14.484

 

6) Fogli M. #, Mavilio D.* #, Brunetta E., Varchetta S., Ata K., Roby G., Kovacs C., Follmann D., Pende D., Ward J., Barker E., Marcenaro E., Moretta A. and Fauci A.S.

Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.

     PLos Pathogens 2008 July 11; 4(7):e1000101. Impact Factor: 9.125

 

7)  Brunetta E., Fogli M., Varchetta S, Bozzo L., Hudspeth K.L., Marcenaro E., Moretta A. and Mavilio D.*.

The decreased expression of Siglec-7 represents an early marker of dysfunctional Natural Killer cell subsets associated with high levels of HIV-1 viremia.

     Blood 2009 October 29, 114(18): 3822-30. Impact Factor: 10.555

 

8) Correia D.V., Fogli M., Hudspeth K.L. Da Silva, M.G., Mavilio D. # and Silva-Santos B.*#

Differentiation of human peripheral blood Vδ1+ T-cells expressing the Natural Cytotoxicity Receptor NKp30 for recognition of lymphoid leukemia cells.

     Blood 2011 Jul 28;118(4):992-1001. Impact Factor: 9.898

 

9) Hudspeth K., Fogli M., Correia D.V., Mikulak J., Roberto A., Della Bella S., Silva-Santos B.# and Mavilio D.*#

Engagement of NKp30 on Vd1 T-cells induces the production of CCL3, CCL4 and CCL5 and suppresses HIV-1 replication.

     Blood, 2012 Apr 26;119(17):4013-6. Impact Factor: 9.06

 

10) Hudspeth K., Pontarini E., Tentorio P., Cimino M.M., Donadon M., Torzilli G., Lugli E., Della Bella S., Gershwin M.E. and Mavilio D.*

The Role of Natural Killer Cells in Autoimmune Liver Disease: A Comprehensive Review.

       Journal of Autoimmunity, November 2013, 46 (2013) 55e65. Impact Factor: 7.018

 

11) Varchetta S., Lusso P., Hudspeth K., Mikulak J., Mele D., Paolucci S., Cimbro R., Malnati M., Riva A. , Maserati R., Mondelli M.U. and Mavilio D.*

Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophages

     Retrovirology. 2013 Dec 13;10(1):154. Impact Factor: 4.767

  

12) Mikulak J, Bozzo L, Roberto A, Pontarini E, Tentorio P, Hudspeth K, Lugli E, Mavilio D.*

Dopamine Inhibits the Effector Functions of Activated NK Cells via the Upregulation of the D5 Receptor.

     Journal of Immunology 2014 Sep 15;193(6):2792-800. Impact Factor: 4.922

 

13) Roberto A., Castagna L., Zanon V., Bramanti S., Crocchiolo R., McLaren J.E., Gandolfi S., Tentorio P., Sarina B., Timofeeva I., Santoro A., Carlo-Stella C., Bruno B., Carniti C., Corradini P., Gostick E., Ladell K., Price D.A., Roederer M., Mavilio D. #* and Lugli E#*.

Role of naïve-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation.

       Blood. 2015 Apr 30;125(18):2855-64. Impact Factor: 11.841

 

14) Pontarini E., Fabris M., Quartuccio L., Cappelletti M., Calcaterra F., Roberto A., Curcio F., Mavilio D. #*, Silvia Della Bella# and De Vita S.

Treatment with belimumab restores B cell subsets and their expression of BAFF receptor in patients with primary Sjogren’s syndrome.

     Rheumatology 2015 Aug;54(8):1429-34. Impact Factor: 4.524

 

15) Mattiola I., Pesant M., Tentorio P., Molgora M., Marcenaro E., Lugli E., Locati M.#* and Mavilio D. #*

Priming of human resting NK cells by autologous M1 macrophages via the engagement of IL-1b, IFN-β and IL-15 pathways

     Journal of Immunology 2015 Sep 15;195(6):2818-28. Impact Factor: 4.985

 

16) Hudspeth K, Donadon M., Cimino M., Pontarini E., Tentorio P., Preti M., Hong M., Bertoletti A., Bicciato S., Invernizzi P., Lugli E., Torzilli G., Gershwin M.E.*, Mavilio D.*

Human liver-resident CD56bright/CD16neg NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways.

     J Autoimmun. 2016 Jan;66:40-50. Impact Factor: 7.760

 

17) Mikulak J.*, Oriolo F., Portale F., Tentorio P., Lan X., Saleem M.A., Skorecki K., Singhal P.C. and Mavilio D.*

Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes.

     Retrovirology, 2016 Sept. 6,13(63). Impact Factor: 3.897

 

18) Calcaterra F, Brambilla L., Colombo E., Tourlaki A., Veraldi S., Carenza C., Mavilio D # and Della Bella S. #*.

Increased frequency and vasculogenic potential of endothelial colony-forming cells in patients with Kaposi’s sarcoma.

     Journal of Investigative Dermatology, 2017;137(7), 1533-1540. Impact Factor: 6.448

 

19) Mikulak J., Oriolo F., Zaghi E., Di Vito C. and Mavilio D.

Natural Killer cells in HIV-1 infection and therapy.

     AIDS, 2017 Nov 13;31(17):2317-2330. Impact Factor: 4.914

 

20) Roberto A, Di Vito C., Zaghi E., Mazza E.M.C., Capucetti A., Calvi M., Tentorio P., Zanon V., Sarina B., Mariotti J., Bramanti S., Tenedini E., Tagliafico E., Bicciato S., Santoro A., Roederer M., Marcenaro E., Castagna L., Lugli E#*. and Mavilio D#*.

The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer represents a therapeutic target in haploidentical haematopoietic stem cell transplantation.

     Haematologica. 2018 Aug;103(8):1390-1402. Impact Factor: 7.570

 

21) Pontarini#, Lucchesi D. #, Fossati-Jimack L., Coleby R., Tentorio P., Croia C., Bombardieri M# and Mavilio D. #*

NK cell recruitment in salivary glands provides early viral control but is dispensable for tertiary lymphoid structure formation.

      J Leukoc Biol. 2019 Mar;105(3):589-602. Impact Factor: 4.012

 

22) Di Vito C., Mikulak J., Zaghi E., Pesce S, Marcenaro E. #* and Mavilio D. #*

NK cells to cure cancer.

     Seminars in Immunology, 2019 May 10. https://doi.org/10.1016/j.smim.2019.03.004

[Epub ahead of print]. Impact Factor: 7.358

 

23) Della Bella S. #*, Calcaterra F.#, Bacci M., Carenza C., Pandolfo C., Ferrazzi P., Uva P., Pagani M., Lodigiani C.# and Mavilio D.#*

Pathologic up-regulation of TNFSF15-TNFRSF25 axis sustains endothelial dysfunction in unprovoked venous thromboembolism.

     Cardiovascular Research, 2019 May 28. pii: cvz131. doi: 10.1093/cvr/cvz131.

[Epub ahead of print]. Impact Factor: 7.014

 

24) Mikulak J#, Oriolo F#, Bruni E#, Roberto A, Colombo FS, Villa A, Bosticardo M, Bortolomai I, Lo Presti E, Meraviglia S, Dieli F, Vetrano S, Danese S, Della Bella S, Carvello MM, Sacchi M, Cugini G, Colombo G, Klinger M, Spaggiari P, Roncalli M, Prinz I, Ravens S, Di Lorenzo B, Marcenaro E, Silva-Santos B, Spinelli A, Mavilio D.#*

NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer.

     JCI Insight, 2019 Dec 19;4(24). Impact Factor: 6.014

 

25) Bruni E, Cazzetta V, Donadon M, Cimino M, Torzilli G, Spata G, Leonardi G, Dieli F, Mikulak J#, Mavilio D.#*

Chemotherapy accelerates immune-senescence and functional impairments of Vδ2pos T cells in elderly patients affected by liver metastatic colorectal cancer.

     Journal for ImmunoTherapy of Cancer, 2019 December 11;7(1):347. Impact Factor: 8.728

 

 

* Corresponding Author / # Shared Authorship